“AmEx Pharmacy recalls BEVACIZUMAB syringes with difficult delivery system.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38897-amex-pharmacy-recalls-bevacizumab-syringes-with-difficult-delivery-system. Based on FDA recall #D-1271-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1271-2019%22&limit=1).
The FDA announced on April 19, 2019, that Pacifico National, Inc. dba AmEx Pharmacy voluntarily recalled BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection due to a defective delivery system that is difficult to express. The recall affects 249 syringes distributed nationwide.
How to tell if you have it
Brand: AmEx Pharmacy
Product: BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection
Lot code: 190212AB
BUD: 5/13/2019
Repackaged on: 2/12/2019
The hazard
The biologic product was repackaged by AmEx Pharmacy and presents a hazard of a defective delivery system that is difficult to express. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Pacifico National, Inc. dba AmEx Pharmacy has two other recalls on record since January 20, 2015. On August 30, 2019, the company issued a recall for Bevacizumab Syringes due to a lack of sterility assurance. Other recent recalls of similar products include Amneal Estradiol Gel Recall (September 8, 2026), ANI Pharmaceuticals Recalls Estradiol Gel (May 12, 2026), and Meclizine 12.5mg Tablets Recall (March 16, 2026).
How to tell if you have this one
Check for lot number 190212AB on the syringe packaging. The syringes were repackaged by AmEx Pharmacy on February 12, 2019.
Brand
AmEx Pharmacy
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Syringe Lot Number
Look for lot number 190212AB on the syringe packaging to confirm if it is recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 22 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1271-2019 (April 19, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1271-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.